text size: T | T
Back to Snapshot
Company Description

Contact Info

1 North Waukegan Road

North Chicago, IL 60064

United States

Phone: 847-932-7900

Fax:

specialty pharmacies, and independent retailers from the company-owned distribution centers and public warehouses. In the United States, the company distributes pharmaceutical products principally through independent wholesale distributors, with some sales directly to pharmacies and patients. In 2015, three wholesale distributors (McKesson Corporation; Cardinal Health, Inc.; and AmerisourceBergen Corporation) accounted for all of the company’s sales in the United States. Certain products are co-marketed or co-promoted with other companies. Research and Development The company spent approximately $4.3 billion on research to discover and develop new products, indications and processes and to improve existing products and processes in 2015. Significant Events In June 2016, AbbVie and Boehringer Ingelheim have announced a global collaboration to develop and commercialize BI 655066, an anti-IL-23 monoclonal biologic antibody in Phase III development for psoriasis. In July 2015, AbbVie and Bristol-Myers Squibb Company announced a clinical trial collaboration to evaluate the safety, tolerability and efficacy of AbbVie's investigational biomarker-specific antibody drug conjugate Rova-T in combination with Bristol-Myers Squibb's Opdivo and Opdivo + Yervoy regimen as a treatment for relapsed extensive-stage small cell lung cancer. Regulation The company’s operations are affected by trade regulations in many countries that limit the import of raw materials and finished products and by laws and regulations that seek to prevent corruption and bribery in the marketplace (including the United States Foreign Corrupt Practices Act and the United Kingdom Bribery Act, which provide guidance on corporate interactions with government officials) and require safeguards for the protection of personal data. History AbbVie Inc. was incorporated in Delaware in 2012.

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

ABBV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ABBV.
View Industry Companies
 

Industry Analysis

ABBV

Industry Average

Valuation ABBV Industry Range
Price/Earnings 19.9x
Price/Sales 4.5x
Price/Book 23.1x
Price/Cash Flow 19.6x
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ABBVIE INC, please visit www.abbvie.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.